MDMG.L Regulatory News (MDMG)

RESULTS OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS

15 April 2016, Moscow, Russia - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, today announces that the Company held its Annual General Meeting of shareholders.

The AGM was at Lapino hospital, Lapino 111, Odintsovskiy district, Moscow Region, Russian Federation at 10.00 a.m. local time, and had a 100% quorum with 75,125,010 shares present.

The AGM passed the following resolutions by a majority of members:

1. To receive and consider the consolidated financial statements of the Company for the financial year ended 31 December 2015, together with the reports of the directors and independent auditors.

2. To appoint KPMG as auditors of the Company, to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of the auditors.

3. To appoint Mr. Mark Kurtser as a non-executive director of the Company and the Chairman of the Board of Directors without remuneration, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

4. To appoint Mr. Simon Rowlands as an independent, non-executive director of the Company with an annual gross remuneration of RUB 4,500,000, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

5. To appoint Mr. Kirill Dmitriev as a non-executive director of the Company without remuneration, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

6. To appoint Ms. Elena Mladova as an executive director of the Company without remuneration, to hold such office until the conclusion of the annual general meeting of the Company to be held in 2018.

7. The payment of a dividend, out of the profits made during the year 2015, in the amount of RUR 6,66 per share. The dividend record date is set as April 22, 2016. The pay date for GDR holders is set as May 20, 2016.

The Minutes of the AGM are available for viewing at the registered office of the Company at Dimitriou Karatasou, 15, Anastasio building, 6th floor, Flat/Office 601, Strovolos, 2024, Nicosia, Cyprus and will shortly be available at the National Storage Mechanism of the UK Listing Authority, located at www.morningstar.co.uk/uk/.

Board of Directors hold a meeting on April 15, 2016 and considered decisions that were approved on Annual General Meeting of shareholders. Taking into account the decisions taken, the Board of Directors and the committees does not change.

The Board has also considered payment of dividends to shareholders twice a year. Decision on dividends payment for the first half of the year will be made by the Board of Directors based on the audited financial results of MD Medical Group for 6 months ended June 30, 2016; the payment of dividends based on the results of the full year will be approved by the General Meeting of shareholders.

For further information please contact:

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 30 modern healthcare facilities, including 4 hospitals and 26 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Kostroma, Ryazan, Novokuznetsk, Krasnoyarsk, Omsk, and Barnaul.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.